Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of HSK3486 on Cardiac Repolarization in Healthy Subjects
NCT06379867Phase 1Recruiting
- Sponsor
- Haisco Pharmaceutical Group Co., Ltd.
- Start
- Apr 2024
- Primary completion
- May 2024
- Modality
- Allosteric Modulators
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of ciprofol in general anesthesia (3 arms), sponsored by Haisco Pharmaceutical Group Co., Ltd. Primary endpoint: Change in Individual Correction QT Interval. Started Apr 2024; status: recruiting.
02
Drugs
ciprofol
03
Conditions
general anesthesia
Beyond the preview
Go deeper on NCT06379867.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06379867.